vaccine in healthy adults: A large-scale, randomised, double-blind placebocontrolled, phase 3 trial. Lancet 376:895-902.

Zolla-Pazner, S., X. P. Kong, X. Jiang, T. Cardozo, A. Nadas, S. Cohen, M. Totrov, M. S. Seaman, S. Wang, and S. Lu. 2011. Cross-clade HIV-1 neutralizing antibodies induced with V3-scaffold protein immunogens following priming with gp120 DNA. J Virol.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement